Open Access

Panel discussion and Q&A - Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice.

Congress Session

About the speakers

Professor Elaine Hylek

Boston University, Boston (United States of America)
11 presentations
0 follower

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

4 more presentations in this session

NOACs: key features on safety, continuity, and reversibility.

Speaker: Professor E. Hylek (Boston, US)

Thumbnail

Unlocking the data: interpreting real-world evidence to inform treatment decisions.

Speaker: Professor T. Villines (Charlottesville, US)

Thumbnail

GLORIA-AF: latest results from this prospective study.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Reversal matters: comprehensive care with dabigatran and idarucizumab.

Speaker: Professor H. Darius (Berlin, DE)

Thumbnail

Access the full session

Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice

Speakers: Professor E. Hylek, Professor H. Darius, Professor E. Hylek, Professor T. Villines, Professor G. Lip...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

Open Access

Welcome and introduction.

21 May 2022

Open Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

4 April 2022

Open Access

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

28 August 2021

This platform is supported by

logo Novo Nordisk